SÖZ
ALTI
NEWS
Home
The day in news
This week
Archive
Crisis
About
EN
AZ
sözaltı
news
Finance
Finance
EN
AZ
Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure
finance.yahoo.com
12.09.2026 12:48
48 views
Copy link
Save
Pick
Edit
Copy link
WhatsApp
Telegram
X
Reddit
Facebook
LinkedIn
Email
More
Image
Share image
Save
Copy link
Similar stories
2 outlets
See how this story developed, hour by hour
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%
finance.yahoo.com
08.09.2026
Why Novartis’ Drug Trial Results Are Blowing Up Amgen Stock
barrons.com
08.09.2026
Related stories
Will Anthropic pull off a November IPO? Time is running out to file key paperwork.
marketwatch.com · 24.10
Investors piled a record sum into a leveraged semiconductor ETF last week. Things didn’t work out.
marketwatch.com · 23.10
Xi gathers China’s top cadres with focus on discipline
ft.com · 23.10
Some Republicans are opposing Trump on tariffs. Maine’s Susan Collins just got him to back down on Canadian levies.
marketwatch.com · 23.10
Trump to cut Canadian tariffs after pressure from Republicans
ft.com · 23.10
The U.S. economy is great by this measure, and the good times aren’t over. So why are Americans so sour?
marketwatch.com · 23.10
← Previous
Jim Cramer Discussed The Contradictions Surrounding NVIDIA Corporation (NASDAQ:NVDA)’s Shares
Next →
Jim Cramer Notes lululemon (LULU) is “Executing Really Poorly”